VAZALORE Featured in Prominent Publication as Promising Alternative to Current Aspirin Options for Secondary Prevention of Cardiac EventsSPARTA, N. J.,…
YONKERS, N.Y., May 20, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX) (ContraFect), a late clinical-stage biotechnology company focused on…
SINGAPORE, May 20, 2022 (GLOBE NEWSWIRE) -- ALR Technologies Inc. (“ALRT USA”) (OTCQB: ALRT), the diabetes management company, today announces…
SYDNEY, AUSTRALIA, May 20, 2022 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology…
MONTREAL, May 20, 2022 (GLOBE NEWSWIRE) -- The Daughters of the Nile is an international organization of women dedicated to…
GAITHERSBURG, Md., May 20, 2022 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr.…
WATERTOWN, Mass., May 20, 2022 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein…
Presentation available for on demand download beginning Tuesday May 24, 2022 at 7:00 AM ETNEW YORK, May 20, 2022 (GLOBE…
- PTR-01 was well-tolerated over a four-month treatment period in RDEB patients - Treatment with PTR-01 led to rapid, consistent,…
Q1 financial filings expected after-market May 30, with management conference call following dayTORONTO, May 20, 2022 (GLOBE NEWSWIRE) -- Entourage…